Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Ito

Showing results (371-380 of 386) with videos related to

Pageof 39
Sort By:
Modern Rheumatology|December 7, 2016
Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategyFumio Hirano, Waka Yokoyama, Hayato Yamazaki, et al.
The Journal of Rheumatology|April 19, 2011
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm SafetyYukiko Komano, Michi Tanaka, Toshihiro Nanki, et al.
Nature Communications|April 15, 2016
Explosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilmsLynne Turnbull, Masanori Toyofuku, Amelia L Hynen, et al.
Journal of Imaging Informatics in Medicine|September 17, 2024
Teleradiology-Based Referrals for Patients with Gastroenterological Diseases Between Tertiary and Regional Hospitals: A Hospital-to-Hospital ApproachKosuke Suzuki, Hiroaki Saito, Yoshika Saito, et al.
Arthritis Care & Research|March 17, 2012
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritisRyoko Sakai, Yukiko Komano, Michi Tanaka, et al.
Cancer Medicine|December 8, 2022
CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphomaJunya Yamaguchi, Fumiharu Ohka, Chalise Lushun, et al.
Plos One|June 23, 2016
Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: A Case-Control Association StudyYuki Hachiya, Aya Kawasaki, Shomi Oka, et al.
Plos One|October 7, 2014
Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association studyAya Kawasaki, Hiroshi Furukawa, Nao Nishida, et al.
Modern Rheumatology|August 8, 2024
Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective studyTakako Miyamae, Yusuke Manabe, Takahiko Sugihara, et al.
Annals of the Rheumatic Diseases|April 17, 2012
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target moleculesRyoko Sakai, Michi Tanaka, Toshihiro Nanki, et al.
Pageof 39

Showing results (371-380 of 386) with videos related to

Sort By:
Pageof 39
Modern Rheumatology|December 7, 2016
Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategyFumio Hirano, Waka Yokoyama, Hayato Yamazaki, et al.
The Journal of Rheumatology|April 19, 2011
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm SafetyYukiko Komano, Michi Tanaka, Toshihiro Nanki, et al.
Nature Communications|April 15, 2016
Explosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilmsLynne Turnbull, Masanori Toyofuku, Amelia L Hynen, et al.
Journal of Imaging Informatics in Medicine|September 17, 2024
Teleradiology-Based Referrals for Patients with Gastroenterological Diseases Between Tertiary and Regional Hospitals: A Hospital-to-Hospital ApproachKosuke Suzuki, Hiroaki Saito, Yoshika Saito, et al.
Arthritis Care & Research|March 17, 2012
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritisRyoko Sakai, Yukiko Komano, Michi Tanaka, et al.
Cancer Medicine|December 8, 2022
CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphomaJunya Yamaguchi, Fumiharu Ohka, Chalise Lushun, et al.
Plos One|June 23, 2016
Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: A Case-Control Association StudyYuki Hachiya, Aya Kawasaki, Shomi Oka, et al.
Plos One|October 7, 2014
Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association studyAya Kawasaki, Hiroshi Furukawa, Nao Nishida, et al.
Modern Rheumatology|August 8, 2024
Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective studyTakako Miyamae, Yusuke Manabe, Takahiko Sugihara, et al.
Annals of the Rheumatic Diseases|April 17, 2012
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target moleculesRyoko Sakai, Michi Tanaka, Toshihiro Nanki, et al.
Pageof 39